Bristol-Myers Squibb Co (BMY)
43.99
+0.29
(+0.66%)
USD |
NYSE |
May 03, 16:00
43.97
-0.02
(-0.05%)
After-Hours: 20:00
Bristol-Myers Squibb Accounts Payable (Quarterly): 3.539B for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.539B |
December 31, 2023 | 3.259B |
September 30, 2023 | 2.813B |
June 30, 2023 | 3.069B |
March 31, 2023 | 3.194B |
December 31, 2022 | 3.04B |
September 30, 2022 | 2.595B |
June 30, 2022 | 2.882B |
March 31, 2022 | 2.944B |
December 31, 2021 | 2.949B |
September 30, 2021 | 2.695B |
June 30, 2021 | 3.609B |
March 31, 2021 | 2.972B |
December 31, 2020 | 2.713B |
September 30, 2020 | 2.441B |
June 30, 2020 | 2.852B |
March 31, 2020 | 3.069B |
December 31, 2019 | 2.445B |
September 30, 2019 | 1.888B |
June 30, 2019 | 2.005B |
March 31, 2019 | 1.976B |
December 31, 2018 | 1.892B |
September 30, 2018 | 1.773B |
June 30, 2018 | 1.873B |
March 31, 2018 | 1.725B |
Date | Value |
---|---|
December 31, 2017 | 2.248B |
September 30, 2017 | 1.699B |
June 30, 2017 | 1.551B |
March 31, 2017 | 1.503B |
December 31, 2016 | 1.664B |
September 30, 2016 | 1.407B |
June 30, 2016 | 1.504B |
March 31, 2016 | 1.543B |
December 31, 2015 | 1.565B |
September 30, 2015 | 1.249B |
June 30, 2015 | 1.839B |
March 31, 2015 | 2.346B |
December 31, 2014 | 2.487B |
September 30, 2014 | 2.568B |
June 30, 2014 | 2.405B |
March 31, 2014 | 2.502B |
December 31, 2013 | 2.559B |
September 30, 2013 | 2.466B |
June 30, 2013 | 2.346B |
March 31, 2013 | 2.079B |
December 31, 2012 | 2.202B |
September 30, 2012 | 2.085B |
June 30, 2012 | 2.134B |
March 31, 2012 | 2.385B |
December 31, 2011 | 2.603B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.888B
Minimum
Sep 2019
3.609B
Maximum
Jun 2021
2.849B
Average
2.913B
Median
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.628B |
Gilead Sciences Inc | 550.00M |
Johnson & Johnson | 8.174B |
Karuna Therapeutics Inc (DELISTED) | 6.783M |
2seventy bio Inc | 6.028M |